Domov › Meduloblastom › Kalifornija
Klinične študije za Meduloblastom v Kalifornija
6 študij za Meduloblastom išče udeležence na lokacijah v Kalifornija.
Mesta v Kalifornija
Uradno besedilo študije (angleško)
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
- University of California, San Francisco, San Francisco
Vključevanje udeležencevFaza 1/2
Starost 1–25 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07346157Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
Vključevanje udeležencevFaza 2
59 Months · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT05535166GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Lucile Packard Children's Hospital Stanford, Palo Alto
Vključevanje udeležencevFaza 1
Starost 1–30 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07087002A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- Children's Hospital Los Angeles, Los Angeles
- in še 6
Vključevanje udeležencevFaza 3
Starost 4–21 · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT05382338DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- UCSF Benioff Children's Hospital Oakland, Oakland
- UC Davis Comprehensive Cancer Center, Sacramento
- Rady Children's Hospital, San Diego
- in še 1
Vključevanje udeležencevFaza 2
Do 21 let · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT04696029Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Children's Hospital of Los Angeles, Los Angeles
- Rady Children's Hospital, San Diego
- University of California, San Francisco, San Francisco
Vključevanje udeležencev
12 Months – 39 Years · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05057702Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.